Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 44 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Aethlon Medical Inc | AEMD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.5119 | 06:00:01 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.5119 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 4 | 44 | - | 1.35 - 5.917 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 07:12:42 | 1 | US$ 1.54 | USD |
Aethlon Medical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.96M | 2.62M | - | 574k | -12.03M | -4.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aethlon Medical News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AEMD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.43 | 1.55 | 1.35 | 1.46 | 10,922 | 0.0819 | 5.73% |
| 1 Month | 1.79 | 1.7999 | 1.35 | 1.58 | 8,475 | -0.2781 | -15.54% |
| 3 Months | 1.80 | 1.88 | 1.35 | 1.67 | 8,231 | -0.2881 | -16.01% |
| 6 Months | 1.42 | 2.3499 | 1.35 | 1.87 | 14,009 | 0.0919 | 6.47% |
| 1 Year | 5.70 | 5.917 | 1.35 | 3.73 | 139,866 | -4.19 | -73.48% |
| 3 Years | 19.10 | 124.90 | 1.35 | 46.78 | 1,272,758 | -17.59 | -92.08% |
| 5 Years | 7.692 | 124.90 | 1.35 | 38.50 | 1,170,987 | -6.18 | -80.34% |
Aethlon Medical Description
| Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment. |
